The weekly litigation news digest is live. Subscribe now

IP Verse

Liquid Pharmaceutical Composition

Patent No. EP3403646 (titled "Liquid Pharmaceutical Composition") was filed by Fresenius Kabi Deutschland on May 15, 2015. The application was issued on Sep 28, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOGENOct 5, 2022PATENT BOUTIQUE
BIOGENOct 5, 2022POHLMAN
SAMSUNG BIOEPISOct 5, 2022PATENT BOUTIQUE
SAMSUNG BIOEPISOct 5, 2022POHLMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3403646

FRESENIUS KABI DEUTSCHLAND
Application Number
EP18169979A
Filing Date
May 15, 2015
Status
Granted And Under Opposition
Aug 26, 2022
Publication Date
Sep 28, 2022
External Links
Slate, EP3403646B1, Google Patents